Navigation Links
Frontier CRT-P

ProductsFrontier CRT-P
Company St. Jude Medical, Inc.
Item Frontier CRT-P
Features 
  • Event histogram
  • Auto mode switch event histogram
  • Heart rate histogram
  • Auto mode switch heart rate histogram
  • Auto mode switch histogram peak filtered rate and duration
  • Event record
  • Event snapshots
  • Prediction model
  • Sensor indicated rate histogram
  • Auto-set
Description The Frontier Biventricular Stimulation Device is a three-port (one atrial and two ventricular) multi-chamber device capable of stimulating the heart in a biventricular or left-ventricular fashion to promote resynchronization and improved hemodynamic performance in patients with heart failure.
Info St. Jude Medical, Inc.
Customer Service: (800) 328-9634
Web site: http://www.sjm.com

Related medicine products :

1. Frontier
2. Frontier® CRT-P Biventricular Stimulation Device
3. Frontier Biventricular Stimulation Device
4. Frontier® II CRT-P
Other Medicine News:Health News:Cogdell Spencer Announces Commencement of Common Stock Offering 2Health News:Cogdell Spencer Announces Commencement of Common Stock Offering 3Health News:Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue 2Health News:LCA Hails US Court of Appeals Decision to Affirm Lower Court Ruling Tobacco Companies Guilty of Massive Fraud and Deception 2Health News:LCA Hails US Court of Appeals Decision to Affirm Lower Court Ruling Tobacco Companies Guilty of Massive Fraud and Deception 3Health News:National study finds youth baseball-related injuries down 25 percent 2Health News:More Than 167,000 Fans Flock to Target Facebook Page Helping Donate $3 Million to Ten Charities 2Health News:More Than 167,000 Fans Flock to Target Facebook Page Helping Donate $3 Million to Ten Charities 3Health News:More Than 167,000 Fans Flock to Target Facebook Page Helping Donate $3 Million to Ten Charities 4Health News:Strategic Diagnostics Appoints Kevin J. Bratton as Chief Financial Officer 2Health News:Strategic Diagnostics Appoints Kevin J. Bratton as Chief Financial Officer 3Health News:Strategic Diagnostics Appoints Kevin J. Bratton as Chief Financial Officer 4
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 1Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 1Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 3Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 4Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 1Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 2